Paul J. Clancy

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Madison, WI
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
By: Jennifer Fitzpatrick, Attorney-in-Fact For: Paul Clancy
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Paul J. Clancy

Form 4 holding Director

AGIOS PHARMACEUTICALS, INC.

Security class
Restricted stock unit
Shares / value
4,975
Estimated value
$123,330
Report date
21 Jun 2022
Price
$24.79
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding Director

AGIOS PHARMACEUTICALS, INC.

Security class
Stock options (right to buy)
Shares / value
29,307
Estimated value
Report date
21 Jun 2022
Price
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding Director

Sionna Therapeutics, Inc.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
17,340
Estimated value
Report date
17 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

INCYTE CORP

Security class
Non Qualfied Stock Option (right to buy)
Shares / value
6,111
Estimated value
Report date
08 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

INCYTE CORP

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
19 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Paul J. Clancy

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .